Pure Global
NCT06406491

Passive Microprocessor-controlled Knees vs. Active Microprocessor-controlled Knees After Transfemoral Amputation

Application Observation of Passive Microprocessor-controlled Knees vs. Active Microprocessor-controlled Knees After Transfemoral Amputation
Median·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Amputation
Drug/Device/Intervention
active microprocessor-controlled knee
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Median
Location
Wiesbaden, Germany
Timeline & enrollment
Phase
N/A
Start date
Apr 23, 2024
End date
Oct 31, 2024
Enrollment
10 participants
Primary outcome

6 minute walk test,Stair Assessment Index (SAI),Hill Assessment Index (SAI)

Summary

This study investigates prosthetic users´ report of passive microprocessor-controlled knees
 (pMPK) vs. active microprocessor-controlled knees (aMPK). Outcome measurements are assessed
 at baseline with the pMPK and after 4 weeks of continuous use of aMPK. Measurements consists
 of functional outcomes, as well as patient-reported outcomes.

ICD-10 classifications
Amputation of limb(s)Traumatic amputation of both feetTraumatic amputation of upper and lower limbs, any combination [any level]Traumatic amputations involving other combinations of body regionsTraumatic amputation of lower leg
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06406491
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06406491 through Pure Global AI's free database. This phase not specified trial is sponsored by Median and is currently Recruiting. The study focuses on Amputation. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.